Company Directory / biotechnology
PrivateFor profitbiotechnologyRedwood City, United States
Genapsys
Transform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnostics
- Founded
- 2010 16 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $319M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
16 years old.
Reach
Website ranked #9,093,649 in the world for traffic, about 445 visits a month.
What it does
BioinformaticsBiotechnologyGeneticsHealth DiagnosticsLife Science
Funding, as listed
$319M currency not stated
- Rounds9
- LatestSeries d, May 2021
- Investors10, 5 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Genapsys, field by field. Contact details are held but never shown.
The company
- Name
- Genapsys
- Type
- For profit
- Status
- Private
- Founded
- 2010
- Founders
- Hesaam Esfandyarpour
- Industry
- biotechnology
- Categories
- Bioinformatics, Biotechnology, Genetics, Health Diagnostics, Life Science
Where
- City
- Redwood City
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #9,093,649
- Monthly web visits
- 445
Funding, as listed
- Total
- 319,000,000 (currency not stated)
- Rounds
- 9
- Latest round
- Series d
- Latest round date
- May 2021
- Investors
- 10
- Lead investors
- 5
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Genapsys may be growing as it is mentioned in the context of a growing third-generation sequencing market, which is projected to reach 23.92 billion dollars globally by 2030, indicating a positive trend in the industry it operates within. The company is listed alongside other key players in the sector, suggesting it is a recognized entity in the biotechnology and genomics field. Additionally, Genapsys' inclusion in discussions during a prominent event like the JP Morgan Healthcare conference implies active engagement with the investment and healthcare community, which can be conducive to growth.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.